HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.
| Revenue (TTM) | $1.36B |
| Gross Profit (TTM) | $970.48M |
| EBITDA | $513.61M |
| Operating Margin | 28.40% |
| Return on Equity | 11.40% |
| Return on Assets | 6.65% |
| Revenue/Share (TTM) | $16.07 |
| Book Value | $24.00 |
| Price-to-Book | 3.76 |
| Price-to-Sales (TTM) | 5.62 |
| EV/Revenue | 6.01 |
| EV/EBITDA | 15.79 |
| Quarterly Earnings Growth (YoY) | 14.70% |
| Quarterly Revenue Growth (YoY) | 7.60% |
| Shares Outstanding | $82.72M |
| Float | $81.02M |
| % Insiders | 2.17% |
| % Institutions | 110.09% |
Volatility is currently contracting
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.
HealthEquity stands out as a beneficiary of durable HSA growth and higher-for-longer interest rates, with AI-driven cash-sorting risks seen as overblown. HQY's earnings are poised for material upside as fixed-rate contracts mature, with incremental net interest income tailwinds and strong account growth supporting double-digit EPS growth. Recent financials highlight robust EBITDA margin expansion, conservative leverage near 1x, and active share repurchases, reducing share count by 4% year-over-year.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.
HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript
HealthEquity NASDAQ: HQY reported accelerated revenue growth and record profitability in its fiscal 2027 second quarter, citing HSA account expansion, higher member engagement and technology-driven service efficiencies. The company raised its full-year outlook after generating record adjusted EBITDA margin of 48%.
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HealthEquity (HQY) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.08 per share a year ago.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HQY and any ticker you trade — then tracks every position and per-strategy win rate.
